How to Buy Bioatla Stock

Bioatla Inc

BioAtla, Inc. , a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

Bioatla stock last closed at $0.41, down 5.14% from the previous day, and has decreased 74.14% in one year. It has overperformed other stocks in the Biotechnology industry by 0.02 percentage points. Bioatla stock is currently +69.17% from its 52-week low of $0.24, and -83.92% from its 52-week high of $2.53.

There are currently 48.59M BCAB shares outstanding. The market cap of BCAB is $19.73M. In the last 24 hours, 198,000 BCAB shares were traded.

How to Buy Bioatla Stock

Wondering how to invest in Bioatla stock? Here's how.

  1. Choose where to buy Bioatla stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Bioatla stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Put funds into your brokerage account: Pick your method of payment and add your info.
  4. Research Bioatla stock: The Bioatla ticker symbol is BCAB. Is Bioatla stock a good investment? Should you buy shares of BCAB? How do BCAB's underlying business fundamentals look? Do top analysts think Bioatla is a good buy? Why has BCAB's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if BCAB is a good stock to buy).
  5. Make your BCAB purchase: Decide if you will purchase BCAB shares at the current market price or use a limit order to buy BCAB shares at a given price.
  6. Get the latest news on your investment in BCAB: Create a watchlist to watch your new investment in Bioatla shares.

Step 1: Choose where to buy Bioatla stock

You will need a brokerage account to access the NASDAQ market and buy BCAB stock.

A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best online stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Technology to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the right brokerage, the next step is to fill out some personal info so you can buy BCAB today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open a new brokerage account.
  1. Submit your info by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have opened your account on the stock trading app, your next step is to transfer the money for your investment:

Watch the video below to see the process of depositing funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Bioatla stock

After you have decided on the best place to buy Bioatla stock, it's absolutely critical to research their stock before you invest, so you truly understand the risk as well as the opportunity.

Bioatla shares at a glance

BCAB Price
$0.41
1w %
-15.77%
1y %
-74.14%
5y %
N/A
P/E
-0.33x
P/B
36.06x
P/S
2.15x
PEG
N/A
Revenue
$11.00M
Earnings
-$61.88M
Fore. Rev. Growth
55.53%
Fore. Earn. Growth
N/A
Market Cap
$19.73M
Next Earnings
N/A
Next Dividend
N/A

Bioatla Fundamentals

WallStreetZen was created to help part-time investors do more accurate fundamental analysis in less time.

You can view all of the due diligence checks on BCAB's stock page.

What is the fair value of BCAB stock?

You can use many financial metrics, analyses, models, and charts to gauge BCAB's intrinsic value.

Using relative valuations metrics:

  • BCAB may be overvalued based on its P/B ratio of 36.06x, relative to Biotechnology industry P/B ratio of 4.66x

You can access more valuation research on BCAB's stock here.

BCAB Financials at a glance

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the BCAB balance sheet.
  • There are more short-term assets than short-term liabilities on the BCAB balance sheet.
  • BCAB has $32.36M in cash and short term investments. This is sufficient to cover its annual cash burn of $57.40M.

Negative Health Checks:

  • BCAB profit margin has gone down from N/A to -562.5% in the past year.
  • BCAB has cash burn of 57396000. It does not have enough cash and short-term investments to cover this.
  • BCAB has a relatively high debt to equity ratio of 69.

Do Wall Street analysts think it's a good time to buy BCAB stock

Out of 1 sell side analysts who monitor BCAB, the consensus analyst rating on BCAB is a Buy

It's important to note that analyst ratings are not recommendations, nor are they financial advice.

You can dive deeper into what analysts are saying on the Bioatla stock forecast page.

BCAB Technical Indicators

SMA10
0.47
SMA20
0.43
SMA50
0.41
SMA100
0.4
SMA200
0.98
MACD
0.01
MACD Signal
0.01
MACD Histogram
0
RSI
44.89
Stochastic %K
31.32
Stochastic %D
45.55
StochRSI %K
19.05
StochRSI %D
37.83

Is BCAB Growing Revenue?

Last year, BCAB revenue was $11.00M. During the past 4 year, BCAB's revenue has gone up by 138.49% per year. This was faster than the Biotechnology industry average of 43.24%.

Learn more about BCAB's earnings and revenue performance here.

Are BCAB insiders buying or selling the stock?

In the past year, insiders at BCAB have sold more shares than they have bought.

Jay M. Phd Short, Chief Executive Officer of BCAB, was the latest BCAB insider to sell. They sold $2,595.92 worth of BCAB shares on May 31, 2025.

Dig into more about who owns BCAB shares here.

Does BCAB stock generate passive income?

No, Bioatla doesn't provide an income stream by paying out dividends.

What others are saying about BCAB

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Make your BCAB purchase

There are two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at a particular dollar amount limit, use a limit order.

Hit the Open Trade button and your broker will execute your order.

If you want additional assistance investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get the latest news on your investment in BCAB

Now that you own some BCAB stock, you'll want to stay up-to-date on your new company.

Create a watchlist to track the latest developments regarding your BCAB stock.

BCAB Feed

How to Buy Stock in Bioatla

To summarize, here are the 6 steps to buy stock in Bioatla:

  1. Choose where to buy Bioatla stock
  2. Create a brokerage account
  3. Put funds into your brokerage account
  4. Research Bioatla stock
  5. Make your BCAB purchase
  6. Get the latest news on your investment in BCAB

If you require a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get the latest news on your new investment in Bioatla, create a watchlist on WallStreetZen today.

NASDAQ: BCAB
$0.41-0.02 (-5.14%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: BCAB
$0.41-0.02 (-5.14%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Bioatla share?

As of Jun 13, 2025, it costs $0.41 to buy one share of Bioatla stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.2, you can buy 0.5 shares of BCAB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Bioatla stock?

According to 1 Wall Street analysts who monitor Bioatla, their consensus recommendation is to buy Bioatla stock.

What is the best way to buy Bioatla stock?

One way to place an order for Bioatla stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.